menu
    • menu

    Company profile for Novavax

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovavaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    21 Firstfield Road Gaithersburg, MD 20878
    Telephone
    Telephone
    (240) 268-2000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.novavax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/novavax
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Plans Black Box Warning For COVID-19 Vaccines: Report
    FDA Plans Black Box Warning For COVID-19 Vaccines: Report

    12 Dec 2025

    // BIOSPACE

    https://www.biospace.com/fda/fda-plans-black-box-warning-for-covid-19-vaccines-report

    BIOSPACE
    12 Dec 2025
    Share Share
    Novavax Transfers U.S. Marketing Rights For Nuvaxovid
    Novavax Transfers U.S. Marketing Rights For Nuvaxovid

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novavax-completes-us-marketing-authorization-transfer-to-sanofi-for-nuvaxovid-triggering-a-25-million-milestone-payment-302603121.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Novavax offloads HQ lease to AstraZeneca in $60M deal
    Novavax offloads HQ lease to AstraZeneca in $60M deal

    23 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/consolidating-novavax-hands-over-keys-maryland-hq-astrazeneca-60m-sale#:~:text=According%20to%20the%20filing%2C%20AstraZeneca,assets%2C%20according%20to%20the%20filing.

    FIERCE PHARMA
    23 Oct 2025
    Share Share
    Novavax Consolidates Sites, Cutting Costs in Alignment Strategy
    Novavax Consolidates Sites, Cutting Costs in Alignment Strategy

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novavax-executes-planned-site-consolidation-further-reducing-cost-footprint-in-line-with-corporate-strategy-302590419.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    Shah Capital Urges Novavax Sale Due To Underperformance
    Shah Capital Urges Novavax Sale Due To Underperformance

    14 Oct 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/shah-capital-pushes-novavaxs-sale-persistent-underperformance-marketing-missteps-2025-10-14/

    REUTERS
    14 Oct 2025
    Share Share
    Novavax Advances Sanofi Partnership With Nuvaxovid EU Marketing
    Novavax Advances Sanofi Partnership With Nuvaxovid EU Marketing

    07 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novavax-continues-to-deliver-on-sanofi-partnership-completing-nuvaxovid-eu-marketing-authorization-transfer-and-triggering-25-million-milestone-payment-302576378.html

    PR NEWSWIRE
    07 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Novavax and get a quotation

    Novavax is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Matrix-A bulk with JDMF offered by Novavax

    Find a price of Matrix-C bulk with JDMF offered by Novavax

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search